Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

November 7, 2022


BURLINGTON, Ontario – November 7, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...

Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

October 24, 2022


BURLINGTON, Ontario – October 24, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...

Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

October 12, 2022


BURLINGTON, Ontario – October 11, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to...

Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada’s Trade Commissioner Service

September 28, 2022


BURLINGTON, Ontario – September 29, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of five Canadian companies accepted into this year’s Venture Mentoring Services program offered by the Maryland Tech...

Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products

September 23, 2022


BURLINGTON, Ontario – September 23, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery platform today announced that they have entered into a supplier and purchase agreement...

Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order

September 12, 2022


BURLINGTON, Ontario – September 12, 2022 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated August 29, 2022, the Company and its auditors are continuing to...

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

August 25, 2022


Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update  BURLINGTON, Ontario – August 25, 2022: Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy...

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

August 11, 2022


Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update BURLINGTON, Ontario – August 11, 2022: Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy...

Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

August 10, 2022


Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement  BURLINGTON, Ontario – August 10, 2022: Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that it has closed on $230,000 in...

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

July 28, 2022


Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update BURLINGTON, Ontario – July 28, 2022: Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy...

1 2 3 4 5 6 7 8 9 10 11